Key result
The L29Q cTnC mutation increased myofilament Ca2+ sensitivity and diminished the Ca2+ desensitizing effect of phosphomimetic cTnI by 68% in a highly sarcomere length-dependent manner.
Effect estimate: ΔKF1/2 -0.45 μM
Absolute Event Rate: 2.95% vs 3.4%
p-value: p=<0.05
The FHC-associated L29Q mutation in cTnC alters myofilament contractility and blunts the desensitizing effects of phosphomimetic cTnI in a sarcomere length-dependent manner, providing mechanistic insights into familial hypertrophic cardiomyopathy.
Caution against extrapolating animal myofilament data to FHC patients; extends sarcomere length-dependent Ca2+ regulation insights but leaves translation open.
The Ca(2+) binding properties of the FHC-associated cardiac troponin C (cTnC) mutation L29Q were examined in isolated cTnC, troponin complexes, reconstituted thin filament preparations, and skinned cardiomyocytes. While higher Ca(2+) binding affinity was apparent for the L29Q mutant in isolated cTnC, this phenomenon was not observed in the cTn complex. At the level of the thin filament in the presence of phosphomimetic TnI, L29Q cTnC further reduced the Ca(2+) affinity by 27% in the steady-state measurement and increased the Ca(2+) dissociation rate by 20% in the kinetic studies. Molecular dynamics simulations suggest that L29Q destabilizes the conformation of cNTnC in the presence of phosphomimetic cTnI and potentially modulates the Ca(2+) sensitivity due to the changes of the opening/closing equilibrium of cNTnC. In the skinned cardiomyocyte preparation, L29Q cTnC increased Ca(2+) sensitivity in a highly sarcomere length (SL)-dependent manner. The well-established reduction of Ca(2+) sensitivity by phosphomimetic cTnI was diminished by 68% in the presence of the mutation and it also depressed the SL-dependent increase in myofilament Ca(2+) sensitivity. This might result from its modified interaction with cTnI which altered the feedback effects of cross-bridges on the L29Q cTnC-cTnI-Tm complex. This study demonstrates that the L29Q mutation alters the contractility and the functional effects of the phosphomimetic cTnI in both thin filament and single skinned cardiomyocytes and importantly that this effect is highly sarcomere length dependent.
No takes yet. Share an insight, caveat, or question.
Li et al. (2013) studied Familial Hypertrophic Cardiomyopathy. L29Q cTnC mutation vs. Wild type (WT) cTnC was evaluated on Ca2+ sensitivity of force generation (KF1/2 in μM) at sarcomere length 2.1 μm (ΔKF1/2 -0.45 μM, p=<0.05). The L29Q cTnC mutation increased myofilament Ca2+ sensitivity and diminished the Ca2+ desensitizing effect of phosphomimetic cTnI by 68% in a highly sarcomere length-dependent manner.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: